Study of ATI-450 Plus Methotrexate (MTX) vs MTX Alone in Patients With Moderate to Severe RA
Clinical trial NCT04247815 · COMPLETED
Trial details
- NCT number
- NCT04247815
- Sponsor
- Aclaris Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-16
- Primary completion
- 2021-02-04
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.